Synthesis and in vitro anti-cancer evaluation of ethylene glycol-saponin loaded on magnetic nanoparticles

Journal of Nanoscience and Nanotechnology

Volumn 10, Issue 10, 2010, Pages 6962-6966

  Lee, Kwon Jai ^a   An, Jeung Hee ^b   Shin, Jae Soo ^c   Kim, Dong Hee ^c  

^a Soongsil University   (South Korea)

^b Sogang University   (South Korea)

^c Daejeon University   (South Korea)

Author keywords

Angiogenesis; Magnetic Nanoparticle; Prostate Cancer; Saponin

Indexed keywords

ANGIOGENESIS; ANTI-INFLAMMATORY ACTIVITY; ANTI-TUMOR ACTIVITIES; AVERAGE SIZE; BIOLOGICAL PROPERTIES; CHEMICAL CO-PRECIPITATION; COMPOSITE NANOPARTICLES; CYTOTOXIC; EXPRESSION LEVELS; EXTRACELLULAR SIGNAL-REGULATED KINASE; IN-VITRO; MAGNETIC NANOPARTICLES; PROSTATE CANCER; PROSTATE CANCER CELLS; PROSTATE CANCERS; SAPONIN; THERAPEUTIC POTENTIALS;

CELL PROLIFERATION; CYTOTOXICITY; ETHYLENE; ETHYLENE GLYCOL; METABOLITES; NANOMAGNETICS; NANOPARTICLES; PRECIPITATION (CHEMICAL);

DISEASES;

ANTINEOPLASTIC AGENT; ETHYLENE GLYCOL DERIVATIVE; MAGNETITE NANOPARTICLE; NANOCOMPOSITE; SAPONIN;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; HUMAN; MALE; NEOVASCULARIZATION (PATHOLOGY); PARTICLE SIZE; PATHOLOGY; PROSTATE TUMOR; RAMAN SPECTROMETRY; SYNTHESIS; TUMOR CELL LINE; VASCULARIZATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ETHYLENE GLYCOLS; HUMANS; MAGNETITE NANOPARTICLES; MALE; NANOCOMPOSITES; NEOVASCULARIZATION, PATHOLOGIC; PARTICLE SIZE; PROSTATIC NEOPLASMS; SAPONINS; SPECTRUM ANALYSIS, RAMAN;

EID: 79952198642     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2010.2985     Document Type: Conference Paper

References (18)

1. K. Hu and X. Yao, Phytotherapy Research 17, 620 (2003)
2. Y. Xie, Y P. Ye, H. X. SUN, and D. Li, Vaccine 26, 3452 (2008).
3. S. G. Sparg, M. E. Light, and J. van Staden, J Ethnopharmacol 94, 219 (2004).
4. M. A. Lacaille-Dubois, Stud. Nat. Prod. Chem. 32, 209 (2005).
5. W. Wang, E. R. Rayburn, M. Hao, Y Zhao, D. L. Hill, R. Zhang, and H. Wang, Prostate 68, 809 (2008).
6. A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, and M. J. Thun , CA Cancer J. Clin. 55, 10 (2005).
7. T. W Flaig, L. J. Su, G. Harrison, R. Agarwal, and L. M. Glode, Int. J. Cancer 120, 2028 (2007).
8. M. J. Moore, D. Osoba, K. Murphy, I. F. Tannock, A. Armitage, B. Findlay, C. Coppin, A. Neville, P. Venner, and J. Wilson, J. Clin. Oncol. 12, 689 (1994).
9. A. S. Lubbe, C. Alexiou, and C. Bergemann, J. Surg Res. 95, 200 (2001).
10. M. S. martina, C. Wilhem, and S. Lesieur, Biomaterials 29, 4137 (2008).
11. K. E. Scarberry, E. B. Dickerson, J. F. McDonald, and Z. J. Zhang, J Am. Chem. Soc. 130, 10258 (2008).
12. K. J. Lee, J. H. An, J. S. Shin, D. H. Kim, C. Kim, H. Ozaki, and J. G. Koh, Nanotechnology 18, 465201 (2007).
13. N. Li, Y Ma, C. Yang, L. Guo, and X. Yang, Biochemical Chemistry 116, 199 (2005).
14. D. L. A. de Faria, S. V. Silva, and M. T. de Oliveiral, J. Raman Spectrosc. 28, 873 (1997).
15. G. V. M Jacintho, P. Corio, and J. C. Rubim, J. Electroanal. Chem. 603, 27 (2007).
16. K. S. K Varadwaj, M. K. Panigrahi, and J. Ghose, J. Solid State Chem. 11, 4286 (2004).
17. C. Igor, D. E. Laurence, N. O. Lazare, J. F. Fouquenet, C. J. Simone, S. Martin, M. Hervé, and D. Pierre, Analyst 130, 1395 (2005).
18. V. G. Roullin, J. R. Deverre, L. Lemaire, F. Hindre, M. C. V. Julienne, R. Vienet and J. P. Benoit, Eur. J. Pharm. Biopharm 53, 293 (2002).